Kuros Biosciences AG (KURN) — Cash Flow Quality Index
Kuros Biosciences AG (KURN) has a Cash Flow Quality Index of 0.54x as of December 2025. Operating cash flow of CHF1.94 Million is below net income of CHF3.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore KURN total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kuros Biosciences AG Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Kuros Biosciences AG across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Kuros Biosciences AG (KURN) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Kuros Biosciences AG (2015–2025)
Year-by-year earnings quality comparison for Kuros Biosciences AG. For live market cap and the full company financial profile, see KURN market cap overview.
| Year | Quality Index | Operating CF (CHF) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.18x | CHF-377.87K | CHF2.04 Million | ▲ +54.2% |
| 2015 | -0.40x | CHF-2.51 Million | CHF6.23 Million | — |